Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Yilmaz

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
Physical Review Letters|September 17, 2019
Dynamical Slowing-Down in an Ultrafast Photoinduced Phase TransitionAlfred Zong, Pavel E Dolgirev, Anshul Kogar, et al.
Journal of Clinical Medicine|November 6, 2019
Short-Term Therapies for Treatment of Acute and Advanced Heart Failure-Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?Piero Pollesello, Tuvia Ben Gal, Dominique Bettex, et al.
European Journal of Heart Failure|May 16, 2025
Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trialMisato Chimura, Mingming Yang, Alasdair D Henderson, et al.
European Heart Journal|August 15, 2021
Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fractionAlice M Jackson, Pardeep S Jhund, Inder S Anand, et al.
European Journal of Heart Failure|May 13, 2016
Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimensMichele Senni, John J V McMurray, Rolf Wachter, et al.
Cardiovascular Drugs and Therapy|August 10, 2013
Renal effects of levosimendan: a consensus reportMehmet B Yilmaz, Elena Grossini, José C Silva Cardoso, et al.
Journal of Cardiac Failure|September 8, 2023
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HFKieran F Docherty, John J V McMurray, Rafael Diaz, et al.
European Journal of Heart Failure|May 6, 2025
Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESCGianluigi Savarese, Gabriele G Schiattarella, Felix Lindberg, et al.
European Journal of Heart Failure|April 30, 2020
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of CardiologyVeli-Pekka Harjola, John Parissis, Johann Bauersachs, et al.
European Journal of Heart Failure|December 17, 2021
Diabetes and pre-diabetes in patients with heart failure and preserved ejection fractionAlice M Jackson, Rasmus Rørth, Jiankang Liu, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Physical Review Letters|September 17, 2019
Dynamical Slowing-Down in an Ultrafast Photoinduced Phase TransitionAlfred Zong, Pavel E Dolgirev, Anshul Kogar, et al.
Journal of Clinical Medicine|November 6, 2019
Short-Term Therapies for Treatment of Acute and Advanced Heart Failure-Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?Piero Pollesello, Tuvia Ben Gal, Dominique Bettex, et al.
European Journal of Heart Failure|May 16, 2025
Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trialMisato Chimura, Mingming Yang, Alasdair D Henderson, et al.
European Heart Journal|August 15, 2021
Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fractionAlice M Jackson, Pardeep S Jhund, Inder S Anand, et al.
European Journal of Heart Failure|May 13, 2016
Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimensMichele Senni, John J V McMurray, Rolf Wachter, et al.
Cardiovascular Drugs and Therapy|August 10, 2013
Renal effects of levosimendan: a consensus reportMehmet B Yilmaz, Elena Grossini, José C Silva Cardoso, et al.
Journal of Cardiac Failure|September 8, 2023
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HFKieran F Docherty, John J V McMurray, Rafael Diaz, et al.
European Journal of Heart Failure|May 6, 2025
Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESCGianluigi Savarese, Gabriele G Schiattarella, Felix Lindberg, et al.
European Journal of Heart Failure|April 30, 2020
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of CardiologyVeli-Pekka Harjola, John Parissis, Johann Bauersachs, et al.
European Journal of Heart Failure|December 17, 2021
Diabetes and pre-diabetes in patients with heart failure and preserved ejection fractionAlice M Jackson, Rasmus Rørth, Jiankang Liu, et al.
Pageof 20